21

Suzhou Basecare Medical Corp LtdHKG 2170 Stock Report

Last reporting period 31 Dec, 2023

Updated 12 Nov, 2024

Last price

Market cap $B

0.05

Micro

Exchange

XHKG - Hong Kong Exchange

2170.HK Stock Analysis

21

Uncovered

Suzhou Basecare Medical Corp Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-23/100

Low score

Market cap $B

0.05

Dividend yield

Shares outstanding

282.71 B

Suzhou Basecare Medical Corp. Ltd. is an investment holding company, which engages in the provision of genetic testing solution for assisted reproduction. The company is headquartered in Suzhou, Jiangsu and currently employs 430 full-time employees. The company went IPO on 2021-02-08. The firm provides genetic testing solutions and sells genetic testing equipment and instruments. The genetic testing solutions include sales of testing kits and provision of testing services. The firm's main products include PGT-A kits. The firm mainly conducts business within the domestic market.

View Section: Eyestock Rating